Calumet, Inc. (NASDAQ:CLMT – Get Free Report) major shareholder Group Heritage sold 626,998 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $32.54, for a total value of $20,402,514.92. Following the completion of the transaction, the insider directly owned 12,980,211 shares of the company’s stock, valued at $422,376,065.94. The trade was a 4.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Calumet Trading Up 3.0%
Shares of NASDAQ:CLMT opened at $32.87 on Friday. Calumet, Inc. has a 12-month low of $12.70 and a 12-month high of $36.94. The company has a market capitalization of $2.86 billion, a PE ratio of -15.22 and a beta of 0.72. The business has a 50 day moving average of $32.02 and a two-hundred day moving average of $25.59.
Calumet (NASDAQ:CLMT – Get Free Report) last announced its quarterly earnings results on Friday, May 8th. The oil and gas company reported ($3.64) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.33) by ($3.31). The business had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1 billion. During the same period in the previous year, the firm earned ($1.87) earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. Equities research analysts predict that Calumet, Inc. will post -0.31 earnings per share for the current fiscal year.
Institutional Trading of Calumet
Wall Street Analysts Forecast Growth
CLMT has been the subject of a number of analyst reports. The Goldman Sachs Group downgraded Calumet from a “buy” rating to a “neutral” rating and set a $36.00 price target for the company. in a report on Friday, April 24th. HC Wainwright boosted their price target on Calumet from $33.00 to $60.00 and gave the company a “buy” rating in a report on Monday, March 30th. TD Cowen upped their target price on Calumet from $19.00 to $25.00 and gave the stock a “hold” rating in a research note on Thursday, March 5th. UBS Group reaffirmed a “neutral” rating and set a $26.00 target price on shares of Calumet in a research note on Friday, February 13th. Finally, Weiss Ratings raised Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $36.75.
Read Our Latest Analysis on CLMT
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Featured Stories
- Five stocks we like better than Calumet
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
